Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of pemafibrate versus placebo with fenofibrate-controlled extension in adults with severe hypertriglyceridemia
2015-003511-37Phase 3Completed
- Sponsor
- Kowa Research Institute, Inc.
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pemafibrate in hypertriglyceridemia and hyperlipidemia (3 arms), sponsored by Kowa Research Institute, Inc. Primary endpoint: Percent change in fasting triglycerides at Week 12. Started Nov 2016; status: completed.
02
Drugs
pemafibrate
03
Conditions
hypertriglyceridemiahyperlipidemia
Beyond the preview
Go deeper on 2015-003511-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003511-37.